Pacerone (amiodarone)Pacerone is a class 3 antiarrhythmic medication with complex mechanisms, including both potassium and sodium channel blockage, along with both beta blocking and calcium channel blocking ability
Amiodarone and dronedarone affect a broad range of channels including sodium, calcium, and multiple potassium channels
We sought to investigate and compare the safety and efficacy of two commonly used antiarrhythmic drugs, Dofetilide (DF) and Sotalol (SL), during inpatient
Background: Switching between antiarrhythmic drugs is timed to minimize arrhythmia recurrence and adverse reactions
30 to 0
BACKGROUND Dofetilide is a class III antiarrhythmic drug commonly used for treatment of atrial fibrillation
Amiodarone is more
Sotalol is cleared from the body through the kidneys and should also be avoided in
In the Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT), amiodarone lowered the
LYLE A
Dofetilide is a class III antiarrhythmic agent ( table 1) available for the acute termination of atrial fibrillation or flutter, as well as prevention of atrial fibrillation or flutter recurrence
Pacerone (amiodarone)Pacerone (amiodarone) is an alternative to Multaq for rhythm control in patients with concomitant congestive heart failure or left ventricular systolic dysfunction
Amiodarone (Cordarone) 150 mg IV over 10 minutes, then 30 to 60 mg IV per hour; 200 to 400 mg orally every day as a maintenance dose after loading: 43 to 68: 8 to 24 hours: 55 to 65: Sotalol The aim of this study was to determine the efficacy and safety of rapid switching from amiodarone to dofetilide (amiodarone discontinued 7 days before dofetilide is started) in AF patients with an ICD
After intravenous electrophysiological testing, both sotalol and amiodarone were predicted to be ineffective in 50 (67%) patients
Furthermore, backup pacing can prevent episodes of bradycardia and risk of TdP
3 Types of interventions arying durations of overlap when amiodarone IV infusion is transitioned to oral administration in cardiothoracic surgery patients
An 89-year-old woman developed acute lung injury following treatment with amiodarone and hypotension following treatment with sotalol for paroxysmal atrial fibrillation [routes, dosages and durations of treatments to reactions onsets not stated]
59) and amiodarone (OR 2
Appendices > 03
68